EarningsORIONPHARM
ORIONPHARM Earnings Update
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 9 November 2020. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Cont. of ORIONPHARM): The Company has reported Consolidated EPS of Tk. 2.84, Consolidated NAV per share (Including Revaluation Surplus) of Tk. 76.77, Consolidated NAV per share (Excluding Revaluation Surplus) of Tk. 68.69 and Consolidated NOCFPS of Tk. 8.04 for the year ended on June 30, 2020 as against Tk. 3.77, Tk. 75.19, Tk. 66.98 and Tk. 6.19 respectively for the same period of the previous year. (end)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace8c5a6b000040055662
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.